Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Maravai LifeSciences May Be Worth $15 to $20 Share in a Takeout - Analyst
Express News | Maravai LifeSciences Shares Are Trading Higher Following a Report Suggesting Repligen Has Approached the Company With an Acquisition Offer
Sector Update: Health Care Stocks Higher in Afternoon Trading
Sector Update: Health Care
Wall Street Ticks Up As Consumer Sentiment Improves; Gold Hits Record Highs, Boosting Mining Stocks: What's Driving Markets Friday?
Express News | Repligen Corp Shares Fall 9% After Report Co Bids to Acquire Maravai LifeSciences
Express News | Maravai LifeSciences Shares Rise 14.6%
Express News | Maravai LifeSciences Shares Resume Trade
Express News | Repligen Corp Has Approached Maravai LifeSciences Holdings Inc With An Acquisition Offer; Maravai LifeSciences Shares Halted To The Upside; Stock Up 11.17%
Express News | RBC Capital Reiterates Outperform on Maravai LifeSciences, Maintains $15 Price Target
Express News | Exclusive-Repligen Corp Has Approached Maravai LifeSciences Holdings Inc With an Acquisition Offer, Sources Say
RBC Capital Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $15
Express News | Maravai LifeSciences : Morgan Stanley Cuts to Equal-Weight From Overweight
Express News | Maravai LifeSciences Shares Down 2.3% Premarket After Morgan Stanley Cuts to Equal-Weight From Overweight
Maravai Cut at Morgan Stanley; Pfizer/BioNTech Headwinds Cited
Unveiling 4 Analyst Insights On Maravai LifeSciences
Express News | Maravai LifeSciences : Morgan Stanley Cuts Target Price to $10.00 From $11.00
Maravai LifeSciences Cut to Equal-Weight From Overweight by Morgan Stanley
Morgan Stanley Downgrades Maravai LifeSciences(MRVI.US) to Hold Rating, Cuts Target Price to $10